Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT03681873
Official study title

Validation of Low Dose CT for Diagnosis of Lung Nodules

Study summary

The investigators have developed an extremely low dose computed tomography (CT) protocol that on preliminary testing has an effective dose in the range of two chest radiographs. The investigators plan to test this exam in patients with known or suspected cancer undergoing clinically indicated chest CT.

Ask AI to explain this study
Start here

Key things to know

Main goalDiagnostic

This describes the study’s primary purpose.

What is being studiedExtremely Low Dose CT

The study team can explain what participation involves.

Who it may be forCancer · Metastasis to Lung

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 15, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Children's Hospital Medical Center, Cincinnati

Study sponsor

01
Study overview

What this study is about

Purpose
Diagnostic
Study type
Interventional
Phase
Not applicable
Sponsor
Children's Hospital Medical Center, Cincinnati
Interventions being studied
Diagnostic Test: Extremely Low Dose CT
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Pediatric and young adult patients (ages 4 to \<21 years)
  • Known or suspected malignancy other than lymphoma
  • Undergoing clinically indicated CT of the chest
Reasons someone may not be able to joinExclusion criteria
  • Pregnancy identified by routine Department of Radiology verbal screening
  • Prior enrollment in the same study (no patient will be enrolled more than once)
  • Inability to provide consent and/or assent
  • Lymphoma

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Cincinnati Children's Hospital Medical Center Burnet CampusCincinnati, Ohio

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 15, 2022. Always confirm current availability with the study team.

View original record ↗